Kraft Heinz Reports Fourth Quarter and Full Year 2022 Results
The Kraft Heinz Company (Nasdaq: KHC) reported strong financial results for Q4 and full year 2022. Q4 net sales increased by 10.0% to $7.4 billion, while organic net sales grew by 10.4%. Net income surged 447.9% to $887 million, and diluted EPS rose 442.9% to $0.72. Adjusted EBITDA increased 8.6% to $1.7 billion. For the full year, net sales reached $26.5 billion, a 1.7% increase, although adjusted EBITDA decreased by 5.8%. Looking ahead, the company forecasts organic net sales growth of 4-6% and adjusted EPS of $2.67 to $2.75 for 2023.
- Q4 net sales increased 10.0% to $7.4 billion.
- Q4 organic net sales grew 10.4%.
- Net income surged 447.9% to $887 million.
- Q4 diluted EPS rose 442.9% to $0.72.
- Adjusted EBITDA increased 8.6% to $1.7 billion.
- Company expects 2023 organic net sales growth of 4-6%.
- Adjusted EBITDA decreased 5.8% for the full year 2022.
- Full year adjusted EPS down 5.1% to $2.78.
- Negative impacts from divestitures and higher supply chain costs.
Provides Full Year 2023 Outlook for Organic
Fourth Quarter Highlights
-
Net sales increased
10.0% , with OrganicNet Sales (1) growth of10.4% .
-
Net income/(loss) increased
447.9% . Adjusted EBITDA(1) increased8.6% .
-
Diluted EPS was
, up$0.72 442.9% . Adjusted EPS(1) was , up$0.85 7.6% .
“2022 was an incredible year for
“The results were even more impressive considering the difficult operating environment, with record levels of inflation and supply chain disruptions, to which our teams responded with agility. I am very proud of the entire
|
|
|
|
|
|
|
|
|
|
|
|
|
||
In millions |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
Organic |
||||||||||
|
|
|
|
|
|
% Chg vs
|
|
YoY Growth
|
|
Price |
|
Volume/
|
||
For the Three Months Ended |
|
|
|
|
|
|
|
|
|
|||||
|
|
$ |
5,684 |
|
$ |
5,208 |
|
|
|
|
|
14.2 pp |
|
(5.0) pp |
International |
|
|
1,697 |
|
|
1,501 |
|
|
|
|
|
18.5 pp |
|
(4.2) pp |
|
|
$ |
7,381 |
|
$ |
6,709 |
|
|
|
|
|
15.2 pp |
|
(4.8) pp |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
For the Year Ended |
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
$ |
20,340 |
|
$ |
20,351 |
|
(0.1)% |
|
|
|
13.0 pp |
|
(3.8) pp |
International |
|
|
6,145 |
|
|
5,691 |
|
|
|
|
|
13.5 pp |
|
(1.9) pp |
|
|
$ |
26,485 |
|
$ |
26,042 |
|
|
|
|
|
13.2 pp |
|
(3.4) pp |
Net Income/(Loss) and Diluted EPS |
|
|
|
|
||||||||||||
In millions, except per share data |
|
|
|
|
|
|
|
|
|
|
||||||
|
|
For the Three Months Ended |
|
For the Year Ended |
||||||||||||
|
|
|
|
|
|
% Chg vs
|
|
|
|
|
|
% Chg vs
|
||||
Gross profit |
|
$ |
2,364 |
|
$ |
2,162 |
|
|
|
$ |
8,122 |
|
$ |
8,682 |
|
(6.5)% |
Operating income/(loss) |
|
|
1,226 |
|
|
(20) |
|
6, |
|
|
3,634 |
|
|
3,460 |
|
|
Net income/(loss) |
|
|
887 |
|
|
(255) |
|
|
|
|
2,368 |
|
|
1,024 |
|
|
Net income/(loss) attributable to common shareholders |
|
|
890 |
|
|
(257) |
|
|
|
|
2,363 |
|
|
1,012 |
|
|
Diluted EPS |
|
$ |
0.72 |
|
$ |
(0.21) |
|
|
|
$ |
1.91 |
|
$ |
0.82 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EPS(1) |
|
|
0.85 |
|
|
0.79 |
|
|
|
|
2.78 |
|
|
2.93 |
|
(5.1)% |
Adjusted EBITDA(1) |
|
$ |
1,743 |
|
$ |
1,606 |
|
|
|
$ |
6,003 |
|
$ |
6,371 |
|
(5.8)% |
Q4 2022 Financial Summary
-
Net sales increased 10.0 percent versus the year-ago period to
, including a positive 7.1 percentage point impact from a 53rd week, a negative 4.6 percentage point impact from divestitures and acquisitions, and a negative 2.9 percentage point impact from currency. Organic$7.4 billion Net Sales increased 10.4 percent versus the prior year period. Price increased 15.2 percentage points versus the prior year period, with increases in both reportable segments primarily driven by price increases to mitigate rising input costs. Volume/mix declined 4.8 percentage points versus the prior year period, with declines in both reportable segments that were primarily driven by supply constraints and elasticity impacts from pricing actions.
-
Net income/(loss) increased 447.9 percent versus the year-ago period to
, primarily driven by non-cash impairment losses in the prior year period, lower interest expense primarily due to debt extinguishment costs in the prior year period, and higher Adjusted EBITDA versus the prior year period. These factors were partially offset by higher tax expense, an accrual related to the previously disclosed securities class action lawsuit, and unfavorable changes in other expense/(income). Adjusted EBITDA increased 8.6 percent versus the year-ago period to$887 million , including a positive 7.4 percentage point impact from a 53rd week, a negative 4.9 percentage point impact from divestitures and acquisitions, and a negative 2.1 percentage point impact from currency. The remaining year-over-year increase in Adjusted EBITDA is a result of higher pricing and efficiency gains that more than offset higher supply chain costs (reflecting inflationary pressure in procurement, logistics, and manufacturing costs), higher commodity costs (mainly in dairy, packaging materials, energy, and soybean and vegetable oils), as well as unfavorable volume/mix.$1.7 billion
-
Diluted EPS was
, up$0.72 442.9% versus the prior year period, driven by the net income/(loss) factors discussed above. Adjusted EPS(1) was , up 7.6 percent versus the prior year period, primarily driven by results of ongoing operations, a 53rd week, and lower interest expense versus the prior year period. These factors were partially offset by a negative$0.85 impact from divestitures and unfavorable changes in other expense/(income).$0.05
FY 2022 Financial Summary
-
Net Sales increased 1.7 percent versus the year-ago period to , including a negative 8.0 percentage point impact from divestitures and acquisitions, a negative 2.0 percentage point impact from currency, and a positive 1.9 percentage point impact from a 53rd week. Organic$26.5 billion Net Sales increased 9.8 percent versus the prior year period. Price increased 13.2 percentage points versus the prior year period, with increases in both reportable segments primarily driven by price increases to mitigate rising input costs. Volume/mix declined 3.4 percentage points versus the prior year period, with declines in both reportable segments that were primarily driven by supply constraints and elasticity impacts from pricing actions.
-
Net income/(loss) increased 131.3 percent versus the year-ago period to
, driven by lower interest expense primarily due to debt extinguishment costs in the prior year period and lower non-cash impairment losses in the current year period. These factors were partially offset by lower Adjusted EBITDA versus the prior year period and an accrual related to the previously disclosed securities class action lawsuit. Adjusted EBITDA decreased 5.8 percent versus the year-ago period to$2.4 billion , including a negative 6.1 percentage point impact from divestitures and acquisitions, a negative 1.3 percentage point impact from currency, and a positive 1.9 percentage point impact from a 53rd week. The remaining year-over-year decrease in Adjusted EBITDA is primarily a result of higher supply chain costs (reflecting inflationary pressure in procurement, logistics, and manufacturing costs), higher commodity costs (mainly in dairy, packaging materials, soybean and vegetable oils, energy, and meat), and unfavorable volume/mix. These impacts were offset by higher pricing and efficiency gains.$6.0 billion
-
Diluted EPS was
, up 132.9 percent versus the prior year period, primarily driven by the net income/(loss) factors discussed above. Adjusted EPS was$1.91 , down 5.1 percent versus the prior year period, primarily driven by a negative$2.78 impact from divestitures, higher taxes on adjusted earnings, and unfavorable changes in other expense/(income). These factors were partially offset by lower interest expense and a 53rd week.$0.26
-
Year-to-date net cash provided by operating activities was
, down 54.0 percent versus the year-ago period, primarily driven by one-time proceeds from the sale of licenses in connection with the Cheese Transaction in the prior year period, higher cash outflows for inventories primarily related to stock rebuilding, increased input costs, and the acceleration of payments to suppliers attributed to the wind-down of existing product financing arrangements, and lower Adjusted EBITDA. These impacts were partially offset by lower cash outflows for interest, primarily due to prior year reduction of long-term debt. Year-to date Free Cash Flow(1) was$2.5 billion , down 65.2 percent versus the comparable prior year period due to the same drivers of net cash provided by operating activities.$1.6 billion
Outlook
The Company expects 2023 Organic
The Company anticipates high single-digit inflation for the year, with pricing and gross efficiencies contributing to Adjusted Gross Profit Margin(1)(2) recovery. Adjusted Gross Profit Margin expansion is expected to fund incremental investments across technology, marketing, and people.
Adjusted EPS(1)(2) is expected to be
End Notes
(1) |
Organic |
|
(2) |
Guidance for Organic |
Earnings Discussion and Webcast Information
A pre-recorded management discussion of
ABOUT
We are driving transformation at
Forward-Looking Statements
This press release contains a number of forward-looking statements. Words such as “provide,” “deliver,’ “see,” “drive,” “accelerate,” “execute,” “generate,” “anticipate,” “believe,” “continue,” “could,” “expect,” “plan,” “will,” “guidance,” and “outlook,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding the Company's plans, impacts of accounting standards and guidance, growth, legal matters, taxes, costs and cost savings, impairments, dividends, expectations, investments, innovations, opportunities, capabilities, execution, initiatives, and pipeline. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company's control.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, operating in a highly competitive industry; the Company’s ability to correctly predict, identify, and interpret changes in consumer preferences and demand, to offer new products to meet those changes, and to respond to competitive innovation; changes in the retail landscape or the loss of key retail customers; changes in the Company's relationships with significant customers or suppliers, or in other business relationships; the Company’s ability to maintain, extend, and expand its reputation and brand image; the Company’s ability to leverage its brand value to compete against private label products; the Company’s ability to drive revenue growth in its key product categories or platforms, increase its market share, or add products that are in faster-growing and more profitable categories; product recalls or other product liability claims; climate change and legal or regulatory responses; the Company’s ability to identify, complete, or realize the benefits from strategic acquisitions, divestitures, alliances, joint ventures, or investments; the Company's ability to successfully execute its strategic initiatives; the impacts of the Company's international operations; the Company's ability to protect intellectual property rights; the Company’s ability to realize the anticipated benefits from prior or future streamlining actions to reduce fixed costs, simplify or improve processes, and improve its competitiveness; the influence of the Company’s largest stockholder; the Company's level of indebtedness, as well as our ability to comply with covenants under our debt instruments; additional impairments of the carrying amounts of goodwill or other indefinite-lived intangible assets; foreign exchange rate fluctuations; volatility in commodity, energy, and other input costs; volatility in the market value of all or a portion of the commodity derivatives we use; compliance with laws and regulations and related legal claims or regulatory enforcement actions; failure to maintain an effective system of internal controls; a downgrade in the Company's credit rating; the impact of sales of the Company's common stock in the public market; the Company’s ability to continue to pay a regular dividend and the amounts of any such dividends; disruptions in the global economy caused by geopolitical conflicts, including the ongoing conflict between
Non-GAAP Financial Measures
The non-GAAP financial measures provided in this press release should be viewed in addition to, and not as an alternative for, results prepared in accordance with accounting principles generally accepted in
To supplement the financial information provided, the Company has presented Organic
Management uses these non-GAAP financial measures to assist in comparing the Company’s performance on a consistent basis for purposes of business decision making by removing the impact of certain items that management believes do not directly reflect the Company’s underlying operations. The Company believes:
-
Organic
Net Sales , Adjusted EBITDA, Constant Currency Adjusted EBITDA, Adjusted Gross Profit, Adjusted Net Income/(Loss), and Adjusted EPS provide important comparability of underlying operating results, allowing investors and management to assess the Company’s operating performance on a consistent basis; and - Free Cash Flow provides a measure of the Company’s core operating performance, the cash-generating capabilities of the Company’s business operations, and is one factor used in determining the amount of cash available for debt repayments, dividends, acquisitions, share repurchases, and other corporate purposes.
Management believes that presenting the Company’s non-GAAP financial measures is useful to investors because it (i) provides investors with meaningful supplemental information regarding financial performance by excluding certain items, (ii) permits investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate historical performance, and (iii) otherwise provides supplemental information that may be useful to investors in evaluating the Company’s results. The Company believes that the presentation of these non-GAAP financial measures, when considered together with the corresponding GAAP financial measures and the reconciliations to those measures, provides investors with additional understanding of the factors and trends affecting the Company’s business than could be obtained absent these disclosures.
Definitions
Organic
Adjusted EBITDA is defined as net income/(loss) from continuing operations before interest expense, other expense/(income), provision for/(benefit from) income taxes, and depreciation and amortization (excluding restructuring activities); in addition to these adjustments, the Company excludes, when they occur, the impacts of divestiture-related license income (e.g., income related to the sale of licenses in connection with the Cheese Transaction), restructuring activities, deal costs, unrealized losses/(gains) on commodity hedges, impairment losses, certain non-ordinary course legal and regulatory matters, and equity award compensation expense (excluding restructuring activities). The Company also presents Adjusted EBITDA on a constant currency basis (Constant Currency Adjusted EBITDA). The Company calculates the impact of currency on Adjusted EBITDA by holding exchange rates constant at the previous year's exchange rate, with the exception of highly inflationary subsidiaries, for which it calculates the previous year's results using the current year's exchange rate.
Adjusted Gross Profit, Adjusted Net Income/(Loss), and Adjusted EPS are defined as gross profit, net income/(loss), and diluted earnings per share, respectively, excluding, when they occur, the impacts of restructuring activities, deal costs, unrealized losses/(gains) on commodity hedges, impairment losses, certain non-ordinary course legal and regulatory matters, losses/(gains) on the sale of a business, other losses/(gains) related to acquisitions and divestitures (e.g., tax and hedging impacts), nonmonetary currency devaluation (e.g., remeasurement gains and losses), debt prepayment and extinguishment (benefit)/costs, and certain significant discrete income tax items (e.g.,
Free Cash Flow is defined as net cash provided by/(used for) operating activities less capital expenditures. The use of this non-GAAP measure does not imply or represent the residual cash flow for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure.
|
|
|
|
|
Schedule 1 |
||||||
Consolidated Statements of Income (in millions, except per share data) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Year Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Net sales |
$ |
7,381 |
|
$ |
6,709 |
|
$ |
26,485 |
|
$ |
26,042 |
Cost of products sold |
|
5,017 |
|
|
4,547 |
|
|
18,363 |
|
|
17,360 |
Gross profit |
|
2,364 |
|
|
2,162 |
|
|
8,122 |
|
|
8,682 |
Selling, general and administrative expenses, excluding impairment losses |
|
1,138 |
|
|
891 |
|
|
3,575 |
|
|
3,588 |
|
|
— |
|
|
53 |
|
|
444 |
|
|
318 |
Intangible asset impairment losses |
|
— |
|
|
1,238 |
|
|
469 |
|
|
1,316 |
Selling, general and administrative expenses |
|
1,138 |
|
|
2,182 |
|
|
4,488 |
|
|
5,222 |
Operating income/(loss) |
|
1,226 |
|
|
(20) |
|
|
3,634 |
|
|
3,460 |
Interest expense |
|
217 |
|
|
604 |
|
|
921 |
|
|
2,047 |
Other expense/(income) |
|
(42) |
|
|
(104) |
|
|
(253) |
|
|
(295) |
Income/(loss) before income taxes |
|
1,051 |
|
|
(520) |
|
|
2,966 |
|
|
1,708 |
Provision for/(benefit from) income taxes |
|
164 |
|
|
(265) |
|
|
598 |
|
|
684 |
Net income/(loss) |
|
887 |
|
|
(255) |
|
|
2,368 |
|
|
1,024 |
Net income/(loss) attributable to noncontrolling interest |
|
(3) |
|
|
2 |
|
|
5 |
|
|
12 |
Net income/(loss) attributable to common shareholders |
$ |
890 |
|
$ |
(257) |
|
$ |
2,363 |
|
$ |
1,012 |
|
|
|
|
|
|
|
|
||||
Basic shares outstanding |
|
1,226 |
|
|
1,225 |
|
|
1,226 |
|
|
1,224 |
Diluted shares outstanding |
|
1,233 |
|
|
1,225 |
|
|
1,235 |
|
|
1,236 |
|
|
|
|
|
|
|
|
||||
Per share data applicable to common shareholders: |
|
|
|
|
|
|
|
||||
Basic earnings/(loss) per share |
$ |
0.73 |
|
$ |
(0.21) |
|
$ |
1.93 |
|
$ |
0.83 |
Diluted earnings/(loss) per share |
|
0.72 |
|
|
(0.21) |
|
|
1.91 |
|
|
0.82 |
|
|
|
|
|
|
|
|
|
|
|
Schedule 2 |
|||||||
Reconciliation of For the Three Months Ended (dollars in millions) (Unaudited) |
||||||||||||||||||
|
|
|
Currency |
|
Acquisitions
|
|
53rd Week |
|
Organic Net
|
|
Price |
|
Volume/Mix |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
$ |
5,684 |
|
$ |
(35) |
|
$ |
— |
|
$ |
357 |
|
$ |
5,362 |
|
|
|
|
International |
|
1,697 |
|
|
(143) |
|
|
71 |
|
|
97 |
|
|
1,672 |
|
|
|
|
|
$ |
7,381 |
|
$ |
(178) |
|
$ |
71 |
|
$ |
454 |
|
$ |
7,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
$ |
5,208 |
|
$ |
— |
|
$ |
297 |
|
$ |
— |
|
$ |
4,911 |
|
|
|
|
International |
|
1,501 |
|
|
12 |
|
|
26 |
|
|
— |
|
|
1,463 |
|
|
|
|
|
$ |
6,709 |
|
$ |
12 |
|
$ |
323 |
|
$ |
— |
|
$ |
6,374 |
|
|
|
|
Year-over-year growth rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.7) pp |
|
(6.6) pp |
|
7.2 pp |
|
|
|
14.2 pp |
|
(5.0) pp |
International |
|
|
(10.5) pp |
|
2.6 pp |
|
6.7 pp |
|
|
|
18.5 pp |
|
(4.2) pp |
|
|
|
(2.9) pp |
|
(4.6) pp |
|
7.1 pp |
|
|
|
15.2 pp |
|
(4.8) pp |
|
|
|
|
|
|
|
|
|
|
|
Schedule 3 |
|||||||
Reconciliation of For the Year Ended (dollars in millions) (Unaudited) |
||||||||||||||||||
|
|
|
Currency |
|
Acquisitions
|
|
53rd Week |
|
Organic Net
|
|
Price |
|
Volume/Mix |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
$ |
20,340 |
|
$ |
(67) |
|
$ |
— |
|
$ |
357 |
|
$ |
20,050 |
|
|
|
|
International |
|
6,145 |
|
|
(430) |
|
|
279 |
|
|
97 |
|
|
6,199 |
|
|
|
|
|
$ |
26,485 |
|
$ |
(497) |
|
$ |
279 |
|
$ |
454 |
|
$ |
26,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
$ |
20,351 |
|
$ |
— |
|
$ |
1,990 |
|
$ |
— |
|
$ |
18,361 |
|
|
|
|
International |
|
5,691 |
|
|
26 |
|
|
109 |
|
|
— |
|
|
5,556 |
|
|
|
|
|
$ |
26,042 |
|
$ |
26 |
|
$ |
2,099 |
|
$ |
— |
|
$ |
23,917 |
|
|
|
|
Year-over-year growth rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.1)% |
|
(0.4) pp |
|
(10.8) pp |
|
1.9 pp |
|
|
|
13.0 pp |
|
(3.8) pp |
International |
|
|
(8.1) pp |
|
2.8 pp |
|
1.7 pp |
|
|
|
13.5 pp |
|
(1.9) pp |
|
|
|
(2.0) pp |
|
(8.0) pp |
|
1.9 pp |
|
|
|
13.2 pp |
|
(3.4) pp |
|
Schedule 4 |
||||||||||
Reconciliation of Net Income/(Loss) to Adjusted EBITDA (dollars in millions) (Unaudited) |
|||||||||||
|
For the Three Months Ended |
|
For the Year Ended |
||||||||
|
|
|
|
|
|
|
|
||||
Net income/(loss) |
$ |
887 |
|
$ |
(255) |
|
$ |
2,368 |
|
$ |
1,024 |
Interest expense |
|
217 |
|
|
604 |
|
|
921 |
|
|
2,047 |
Other expense/(income) |
|
(42) |
|
|
(104) |
|
|
(253) |
|
|
(295) |
Provision for/(benefit from) income taxes |
|
164 |
|
|
(265) |
|
|
598 |
|
|
684 |
Operating income/(loss) |
|
1,226 |
|
|
(20) |
|
|
3,634 |
|
|
3,460 |
Depreciation and amortization (excluding restructuring activities) |
|
246 |
|
|
233 |
|
|
922 |
|
|
910 |
Divestiture-related license income |
|
(15) |
|
|
(4) |
|
|
(56) |
|
|
(4) |
Restructuring activities |
|
36 |
|
|
32 |
|
|
74 |
|
|
84 |
Deal costs |
|
1 |
|
|
3 |
|
|
9 |
|
|
11 |
Unrealized losses/(gains) on commodity hedges |
|
(2) |
|
|
29 |
|
|
63 |
|
|
17 |
Impairment losses |
|
— |
|
|
1,291 |
|
|
999 |
|
|
1,634 |
Certain non-ordinary course legal and regulatory matters |
|
210 |
|
|
— |
|
|
210 |
|
|
62 |
Equity award compensation expense |
|
41 |
|
|
42 |
|
|
148 |
|
|
197 |
Adjusted EBITDA |
$ |
1,743 |
|
$ |
1,606 |
|
$ |
6,003 |
|
$ |
6,371 |
|
|
|
|
|
|
|
|
||||
Segment Adjusted EBITDA: |
|
|
|
|
|
|
|
||||
|
$ |
1,550 |
|
$ |
1,445 |
|
$ |
5,284 |
|
$ |
5,576 |
International |
|
284 |
|
|
245 |
|
|
1,017 |
|
|
1,066 |
General corporate expenses |
|
(91) |
|
|
(84) |
|
|
(298) |
|
|
(271) |
Adjusted EBITDA |
$ |
1,743 |
|
$ |
1,606 |
|
$ |
6,003 |
|
$ |
6,371 |
|
|
|
|
|
Schedule 5 |
|||
Reconciliation of Adjusted EBITDA to Constant Currency Adjusted EBITDA For the Three Months Ended (dollars in millions) (Unaudited) |
||||||||
|
Adjusted EBITDA |
|
Currency |
|
Constant Currency
|
|||
|
|
|
|
|
|
|||
|
$ |
1,550 |
|
$ |
(8) |
|
$ |
1,558 |
International |
|
284 |
|
|
(26) |
|
|
310 |
General corporate expenses |
|
(91) |
|
|
2 |
|
|
(93) |
|
$ |
1,743 |
|
$ |
(32) |
|
$ |
1,775 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
$ |
1,445 |
|
$ |
— |
|
$ |
1,445 |
International |
|
245 |
|
|
2 |
|
|
243 |
General corporate expenses |
|
(84) |
|
|
— |
|
|
(84) |
|
$ |
1,606 |
|
$ |
2 |
|
$ |
1,604 |
Year-over-year growth rates |
|
|
|
|
|
|
|
|
(0.5) pp |
|
|
International |
|
|
(12.0) pp |
|
|
General corporate expenses |
|
|
(3.2) pp |
|
|
|
|
|
(2.1) pp |
|
|
|
|
|
|
|
Schedule 6 |
|||
Reconciliation of Adjusted EBITDA to Constant Currency Adjusted EBITDA For the Year Ended (dollars in millions) (Unaudited) |
||||||||
|
Adjusted EBITDA |
|
Currency |
|
Constant Currency
|
|||
|
|
|
|
|
|
|||
|
$ |
5,284 |
|
$ |
(14) |
|
$ |
5,298 |
International |
|
1,017 |
|
|
(71) |
|
|
1,088 |
General corporate expenses |
|
(298) |
|
|
9 |
|
|
(307) |
|
$ |
6,003 |
|
$ |
(76) |
|
$ |
6,079 |
|
|
|
|
|
|
|||
|
|
|
|
|
|
|||
|
$ |
5,576 |
|
$ |
— |
|
$ |
5,576 |
International |
|
1,066 |
|
|
6 |
|
|
1,060 |
General corporate expenses |
|
(271) |
|
|
— |
|
|
(271) |
|
$ |
6,371 |
|
$ |
6 |
|
$ |
6,365 |
Year-over-year growth rates |
|
|
|
|
|
|
(5.2)% |
|
(0.2) pp |
|
(5.0)% |
International |
(4.6)% |
|
(7.2) pp |
|
|
General corporate expenses |
|
|
(3.5) pp |
|
|
|
(5.8)% |
|
(1.3) pp |
|
(4.5)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 7 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Three Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision for/
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
2,364 |
|
$ |
1,138 |
|
$ |
1,226 |
|
$ |
217 |
|
$ |
(42) |
|
$ |
1,051 |
|
$ |
164 |
|
$ |
887 |
|
$ |
(3) |
|
$ |
890 |
|
$ |
0.72 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
12 |
|
|
(24) |
|
|
36 |
|
|
— |
|
|
(1) |
|
|
37 |
|
|
9 |
|
|
28 |
|
|
— |
|
|
28 |
|
|
0.02 |
Deal Costs |
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
— |
|
|
1 |
|
|
1 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
(2) |
|
|
— |
|
|
(2) |
|
|
— |
|
|
— |
|
|
(2) |
|
|
(1) |
|
|
(1) |
|
|
— |
|
|
(1) |
|
|
— |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
(210) |
|
|
210 |
|
|
— |
|
|
— |
|
|
210 |
|
|
49 |
|
|
161 |
|
|
— |
|
|
161 |
|
|
0.13 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
24 |
|
|
(24) |
|
|
(15) |
|
|
(9) |
|
|
— |
|
|
(9) |
|
|
(0.01) |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1) |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
|
|
1 |
|
|
— |
Debt prepayment and extinguishment (benefit)/costs |
|
— |
|
|
— |
|
|
— |
|
|
26 |
|
|
— |
|
|
(26) |
|
|
(7) |
|
|
(19) |
|
|
— |
|
|
(19) |
|
|
(0.01) |
Adjusted Non-GAAP Results |
$ |
2,374 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,048 |
|
|
|
|
|
$ |
0.85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 8 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Three Months Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision for/
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
2,162 |
|
$ |
2,182 |
|
$ |
(20) |
|
$ |
604 |
|
$ |
(104) |
|
$ |
(520) |
|
$ |
(265) |
|
$ |
(255) |
|
$ |
2 |
|
$ |
(257) |
|
$ |
(0.21) |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
9 |
|
|
(22) |
|
|
31 |
|
|
— |
|
|
(1) |
|
|
32 |
|
|
8 |
|
|
24 |
|
|
— |
|
|
24 |
|
|
0.02 |
Deal Costs |
|
— |
|
|
(3) |
|
|
3 |
|
|
— |
|
|
— |
|
|
3 |
|
|
1 |
|
|
2 |
|
|
— |
|
|
2 |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
29 |
|
|
— |
|
|
29 |
|
|
— |
|
|
— |
|
|
29 |
|
|
7 |
|
|
22 |
|
|
— |
|
|
22 |
|
|
0.02 |
Impairment losses |
|
— |
|
|
(1,291) |
|
|
1,291 |
|
|
— |
|
|
— |
|
|
1,291 |
|
|
290 |
|
|
1,001 |
|
|
— |
|
|
1,001 |
|
|
0.81 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
33 |
|
|
(33) |
|
|
66 |
|
|
(99) |
|
|
— |
|
|
(99) |
|
|
(0.08) |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
4 |
|
|
(4) |
|
|
— |
|
|
(4) |
|
|
— |
|
|
(4) |
|
|
— |
Debt prepayment and extinguishment (benefit)/costs |
|
— |
|
|
— |
|
|
— |
|
|
(346) |
|
|
— |
|
|
346 |
|
|
68 |
|
|
278 |
|
|
— |
|
|
278 |
|
|
0.23 |
Adjusted Non-GAAP Results |
$ |
2,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
969 |
|
|
|
|
|
$ |
0.79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 9 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Year Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision for/
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
8,122 |
|
$ |
4,488 |
|
$ |
3,634 |
|
$ |
921 |
|
$ |
(253) |
|
$ |
2,966 |
|
$ |
598 |
|
$ |
2,368 |
|
$ |
5 |
|
$ |
2,363 |
|
$ |
1.91 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
27 |
|
|
(47) |
|
|
74 |
|
|
— |
|
|
— |
|
|
74 |
|
|
18 |
|
|
56 |
|
|
— |
|
|
56 |
|
|
0.05 |
Deal Costs |
|
— |
|
|
(9) |
|
|
9 |
|
|
— |
|
|
— |
|
|
9 |
|
|
4 |
|
|
5 |
|
|
— |
|
|
5 |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
63 |
|
|
— |
|
|
63 |
|
|
— |
|
|
— |
|
|
63 |
|
|
15 |
|
|
48 |
|
|
— |
|
|
48 |
|
|
0.04 |
Impairment losses |
|
86 |
|
|
(913) |
|
|
999 |
|
|
— |
|
|
— |
|
|
999 |
|
|
132 |
|
|
867 |
|
|
— |
|
|
867 |
|
|
0.70 |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
(210) |
|
|
210 |
|
|
— |
|
|
— |
|
|
210 |
|
|
49 |
|
|
161 |
|
|
— |
|
|
161 |
|
|
0.13 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
25 |
|
|
(25) |
|
|
(8) |
|
|
(17) |
|
|
— |
|
|
(17) |
|
|
(0.01) |
Other losses/(gains) related to acquisitions and divestitures |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
38 |
|
|
(38) |
|
|
(9) |
|
|
(29) |
|
|
— |
|
|
(29) |
|
|
(0.02) |
Nonmonetary currency devaluation |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(17) |
|
|
17 |
|
|
— |
|
|
17 |
|
|
— |
|
|
17 |
|
|
0.01 |
Debt prepayment and extinguishment (benefit)/costs |
|
— |
|
|
— |
|
|
— |
|
|
38 |
|
|
— |
|
|
(38) |
|
|
(3) |
|
|
(35) |
|
|
— |
|
|
(35) |
|
|
(0.03) |
Adjusted Non-GAAP Results |
$ |
8,298 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,441 |
|
|
|
|
|
$ |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule 10 |
|||||||||||||
Reconciliation of GAAP Results to Non-GAAP Results (dollars in millions) (Unaudited) |
||||||||||||||||||||||||||||||||
|
For the Year Ended |
|||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||
|
Gross
|
|
Selling,
|
|
Operating
|
|
Interest
|
|
Other
|
|
Income/
|
|
Provision for/
|
|
Net
|
|
Net
|
|
Net
|
|
Diluted
|
|||||||||||
GAAP Results |
$ |
8,682 |
|
$ |
5,222 |
|
$ |
3,460 |
|
$ |
2,047 |
|
$ |
(295) |
|
$ |
1,708 |
|
$ |
684 |
|
$ |
1,024 |
|
$ |
12 |
|
$ |
1,012 |
|
$ |
0.82 |
Items Affecting Comparability |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring activities |
|
13 |
|
|
(70) |
|
|
83 |
|
|
— |
|
|
(1) |
|
|
84 |
|
|
20 |
|
|
64 |
|
|
— |
|
|
64 |
|
|
0.05 |
Deal Costs |
|
— |
|
|
(11) |
|
|
11 |
|
|
— |
|
|
— |
|
|
11 |
|
|
7 |
|
|
4 |
|
|
— |
|
|
4 |
|
|
— |
Unrealized losses/(gains) on commodity hedges |
|
17 |
|
|
— |
|
|
17 |
|
|
— |
|
|
— |
|
|
17 |
|
|
4 |
|
|
13 |
|
|
— |
|
|
13 |
|
|
0.01 |
Impairment losses |
|
— |
|
|
(1,634) |
|
|
1,634 |
|
|
— |
|
|
— |
|
|
1,634 |
|
|
310 |
|
|
1,324 |
|
|
— |
|
|
1,324 |
|
|
1.07 |
Certain non-ordinary course legal and regulatory matters |
|
— |
|
|
(62) |
|
|
62 |
|
|
— |
|
|
— |
|
|
62 |
|
|
— |
|
|
62 |
|
|
— |
|
|
62 |
|
|
0.05 |
Losses/(gains) on sale of business |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
44 |
|
|
(44) |
|
|
(225) |
|
|
181 |
|
|
— |
|
|
181 |
|
|
0.15 |
Debt prepayment and extinguishment (benefit)/costs |
|
— |
|
|
— |
|
|
— |
|
|
(917) |
|
|
— |
|
|
917 |
|
|
189 |
|
|
728 |
|
|
— |
|
|
728 |
|
|
0.59 |
Certain significant discrete income tax items |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(235) |
|
|
235 |
|
|
— |
|
|
235 |
|
|
0.19 |
Adjusted Non-GAAP Results |
$ |
8,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,635 |
|
|
|
|
|
$ |
2.93 |
|
Schedule 11 |
|||||||
(Unaudited) |
||||||||
|
For the Three Months Ended |
|
|
|||||
|
|
|
|
|
$ Change |
|||
Key drivers of change in Adjusted EPS: |
|
|
|
|
|
|||
Results of operations(a)(b) |
$ |
0.95 |
|
$ |
0.87 |
|
$ |
0.08 |
Results of divested operations |
|
— |
|
|
0.05 |
|
|
(0.05) |
53rd week |
|
0.06 |
|
|
— |
|
|
0.06 |
Interest expense |
|
(0.16) |
|
|
(0.18) |
|
|
0.02 |
Other expense/(income) |
|
0.02 |
|
|
0.05 |
|
|
(0.03) |
Effective tax rate |
|
(0.01) |
|
|
— |
|
|
(0.01) |
Effect of dilutive equity awards(c) |
|
(0.01) |
|
|
— |
|
|
(0.01) |
Adjusted EPS |
$ |
0.85 |
|
$ |
0.79 |
|
$ |
0.06 |
(a) |
Includes non-cash amortization of definite-lived intangible assets, which accounted for a negative impact to Adjusted EPS from results of operations of |
|
(b) |
Includes divestiture-related license income, which accounted for a benefit to Adjusted EPS from results of operations of |
|
(c) |
Represents the impact of excluding the dilutive equity awards for the three months ended |
|
Schedule 12 |
|||||||
(Unaudited) |
||||||||
|
For the Year Ended |
|
|
|||||
|
|
|
|
|
$ Change |
|||
Key drivers of change in Adjusted EPS: |
|
|
|
|
|
|||
Results of operations(a)(b) |
$ |
3.26 |
|
$ |
3.25 |
|
$ |
0.01 |
Results of divested operations |
|
0.01 |
|
|
0.27 |
|
|
(0.26) |
53rd week |
|
0.06 |
|
|
— |
|
|
0.06 |
Interest expense |
|
(0.63) |
|
|
(0.76) |
|
|
0.13 |
Other expense/(income)(c) |
|
0.14 |
|
|
0.17 |
|
|
(0.03) |
Effective tax rate |
|
(0.06) |
|
|
— |
|
|
(0.06) |
Adjusted EPS |
$ |
2.78 |
|
$ |
2.93 |
|
$ |
(0.15) |
(a) |
Includes non-cash amortization of definite-lived intangible assets, which accounted for a negative impact to Adjusted EPS from results of operations of |
|
(b) |
Includes divestiture-related license income, which accounted for a benefit to Adjusted EPS from results of operations of |
|
(c) |
Includes non-cash amortization of prior service credits, which accounted for a benefit to Adjusted EPS from other expense/(income) of |
|
|
|
Schedule 13 |
||
Consolidated Balance Sheets (in millions, except per share data) (Unaudited) |
|||||
|
|
|
|
||
ASSETS |
|
|
|
||
Cash and cash equivalents |
$ |
1,040 |
|
$ |
3,445 |
Trade receivables, net |
|
2,120 |
|
|
1,957 |
Inventories |
|
3,651 |
|
|
2,729 |
Prepaid expenses |
|
240 |
|
|
136 |
Other current assets |
|
842 |
|
|
716 |
Assets held for sale |
|
4 |
|
|
11 |
Total current assets |
|
7,897 |
|
|
8,994 |
Property, plant and equipment, net |
|
6,740 |
|
|
6,806 |
|
|
30,833 |
|
|
31,296 |
Intangible assets, net |
|
42,649 |
|
|
43,542 |
Other non-current assets |
|
2,394 |
|
|
2,756 |
TOTAL ASSETS |
$ |
90,513 |
|
$ |
93,394 |
LIABILITIES AND EQUITY |
|
|
|
||
Commercial paper and other short-term debt |
$ |
6 |
|
$ |
14 |
Current portion of long-term debt |
|
831 |
|
|
740 |
Trade payables |
|
4,848 |
|
|
4,753 |
Accrued marketing |
|
749 |
|
|
804 |
Interest payable |
|
264 |
|
|
268 |
Income taxes payable |
|
136 |
|
|
541 |
Other current liabilities |
|
2,194 |
|
|
1,944 |
Total current liabilities |
|
9,028 |
|
|
9,064 |
Long-term debt |
|
19,233 |
|
|
21,061 |
Deferred income taxes |
|
10,152 |
|
|
10,536 |
Accrued postemployment costs |
|
144 |
|
|
205 |
Long-term deferred income |
|
1,477 |
|
|
1,534 |
Other non-current liabilities |
|
1,609 |
|
|
1,542 |
TOTAL LIABILITIES |
|
41,643 |
|
|
43,942 |
Redeemable noncontrolling interest |
|
40 |
|
|
4 |
Equity: |
|
|
|
||
Common stock, |
|
12 |
|
|
12 |
Additional paid-in capital |
|
51,834 |
|
|
53,379 |
Retained earnings/(deficit) |
|
489 |
|
|
(1,682) |
Accumulated other comprehensive income/(losses) |
|
(2,810) |
|
|
(1,824) |
|
|
(847) |
|
|
(587) |
Total shareholders' equity |
|
48,678 |
|
|
49,298 |
Noncontrolling interest |
|
152 |
|
|
150 |
TOTAL EQUITY |
|
48,830 |
|
|
49,448 |
TOTAL LIABILITIES AND EQUITY |
$ |
90,513 |
|
$ |
93,394 |
|
Schedule 14 |
||||
Consolidated Statements of Cash Flows (in millions) (Unaudited) |
|||||
|
For the Year Ended |
||||
|
|
|
|
||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
||
Net income/(loss) |
$ |
2,368 |
|
$ |
1,024 |
Adjustments to reconcile net income/(loss) to operating cash flows: |
|
|
|
||
Depreciation and amortization |
|
933 |
|
|
910 |
Amortization of postemployment benefit plans prior service costs/(credits) |
|
(14) |
|
|
(7) |
Divestiture-related license income |
|
(56) |
|
|
(4) |
Equity award compensation expense |
|
148 |
|
|
197 |
Deferred income tax provision/(benefit) |
|
(278) |
|
|
(1,042) |
Postemployment benefit plan contributions |
|
(23) |
|
|
(27) |
|
|
913 |
|
|
1,634 |
Nonmonetary currency devaluation |
|
17 |
|
|
— |
Loss/(gain) on sale of business |
|
(25) |
|
|
(44) |
Proceeds from sale of license |
|
— |
|
|
1,587 |
Loss/(gain) on extinguishment of debt |
|
(38) |
|
|
917 |
Other items, net |
|
7 |
|
|
(187) |
Changes in current assets and liabilities: |
|
|
|
||
Trade receivables |
|
(228) |
|
|
87 |
Inventories |
|
(1,121) |
|
|
(144) |
Accounts payable |
|
152 |
|
|
408 |
Other current assets |
|
(314) |
|
|
(32) |
Other current liabilities |
|
28 |
|
|
87 |
Net cash provided by/(used for) operating activities |
|
2,469 |
|
|
5,364 |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
||
Capital expenditures |
|
(916) |
|
|
(905) |
Payments to acquire business, net of cash acquired |
|
(481) |
|
|
(74) |
Settlement of net investment hedges |
|
208 |
|
|
(28) |
Proceeds from sale of business, net of cash disposed and working capital adjustments |
|
88 |
|
|
5,014 |
Other investing activities, net |
|
10 |
|
|
31 |
Net cash provided by/(used for) investing activities |
|
(1,091) |
|
|
4,038 |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
||
Repayments of long-term debt |
|
(1,465) |
|
|
(6,202) |
Debt prepayment and extinguishment benefit/(costs) |
|
10 |
|
|
(924) |
Proceeds from issuance of commercial paper |
|
228 |
|
|
— |
Repayments of commercial paper |
|
(228) |
|
|
— |
Dividends paid |
|
(1,960) |
|
|
(1,959) |
Other financing activities, net |
|
(299) |
|
|
(259) |
Net cash provided by/(used for) financing activities |
|
(3,714) |
|
|
(9,344) |
Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
|
(69) |
|
|
(30) |
Cash, cash equivalents, and restricted cash |
|
|
|
||
Net increase/(decrease) |
|
(2,405) |
|
|
28 |
Balance at beginning of period |
|
3,446 |
|
|
3,418 |
Balance at end of period |
$ |
1,041 |
|
$ |
3,446 |
|
|
|
Schedule 15 |
||
Reconciliation of Net Cash Provided By/(Used for) Operating Activities to Free Cash Flow (in millions) (Unaudited) |
|||||
|
For the Year Ended |
||||
|
|
|
|
||
Net cash provided by/(used for) operating activities |
$ |
2,469 |
|
$ |
5,364 |
Capital expenditures |
|
(916) |
|
|
(905) |
Free Cash Flow |
$ |
1,553 |
|
$ |
4,459 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230215005101/en/
Alex.Abraham@kraftheinz.com
ir@kraftheinz.com
Source:
FAQ
What were the Q4 2022 results for Kraft Heinz (KHC)?
How did Kraft Heinz (KHC) perform in full year 2022?
What is the 2023 outlook for Kraft Heinz (KHC)?